PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,256 | +2.5% | 33,697 | -25.7% | 0.00% | – |
| Q2 2023 | $686,327 | +73.9% | 45,332 | -7.5% | 0.00% | – |
| Q1 2023 | $394,574 | -8.1% | 48,985 | +28.3% | 0.00% | – |
| Q4 2022 | $429,525 | +194.2% | 38,180 | +99.9% | 0.00% | – |
| Q3 2022 | $146,000 | -60.8% | 19,095 | +13.6% | 0.00% | – |
| Q2 2022 | $372,000 | +26.5% | 16,816 | +3.9% | 0.00% | – |
| Q1 2022 | $294,000 | +12.2% | 16,185 | -11.3% | 0.00% | – |
| Q4 2021 | $262,000 | -15.8% | 18,256 | +4.0% | 0.00% | – |
| Q3 2021 | $311,000 | -16.4% | 17,547 | -12.2% | 0.00% | – |
| Q2 2021 | $372,000 | +175.6% | 19,984 | +313.3% | 0.00% | – |
| Q1 2021 | $135,000 | – | 4,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,261,926 | $57,834,000 | 8.52% |
| venBio Partners LLC | 2,303,310 | $40,838,000 | 4.07% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $56,392,000 | 3.50% |
| Foresite Capital Management V, LLC | 364,142 | $6,456,000 | 2.01% |
| VR Adviser, LLC | 552,882 | $9,803,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,608,471 | $28,518,000 | 0.56% |
| Cormorant Asset Management, LP | 689,731 | $12,229,000 | 0.50% |
| Novo Holdings A/S | 418,943 | $7,428,000 | 0.38% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $42,909,000 | 0.25% |
| DAFNA Capital Management LLC | 35,074 | $622,000 | 0.16% |